tirzepatide diabetic retinopathy risk A study in JAMA Network Open adds to the growing evidence connecting GLP1 receptor agonist drugs with retinopathy. In people with type 2 diabetes, the study found a 7% increased Study: Tirzepatide Lowers Risk of
Description
Both are used to treat type 2 diabetes and can promote weight loss
Between 89% and 91% of participants on the 10 mg or 15 mg doses achieved at least 5% weight loss
You might recognize it under the names Ozempic (for diabetes), Wegovy (for weight loss), or Rybelsus (a tablet form)
These may include hair loss or changes in your face
Join 1,500,000+ PeterMD weight loss patients Lose up to 1.5% of your body fat per week Get access to other great weight loss medications No insurance needed On average, people on Tirzepatide lose 26% of their weight in a year*
Keep in mind, these are out-of-pocket costs
